1![MATEC Web of Conferences 4, DOI: matecconf C Owned by the authors, published by EDP Sciences, 2013 MATEC Web of Conferences 4, DOI: matecconf C Owned by the authors, published by EDP Sciences, 2013](https://www.pdfsearch.io/img/1bcde05e85a11d4f9ccf66d189f41333.jpg) | Add to Reading ListSource URL: cea-proceedings.edpsciences.orgLanguage: English |
---|
2![Microsoft PowerPoint - FDA Thrombogenicity Presentation 14April2014 PPT.pptx [Read-Only] Microsoft PowerPoint - FDA Thrombogenicity Presentation 14April2014 PPT.pptx [Read-Only]](https://www.pdfsearch.io/img/d6f2336ef61d9a10190973059dc6dfbd.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
3![PTT and PT Assays for Thrombogenicity Evaluation: An FDA Perspective Qijin Lu, Ph.D. In Vitro Blood Damage Assessment Lab Division of Solid and Fluid Mechanics PTT and PT Assays for Thrombogenicity Evaluation: An FDA Perspective Qijin Lu, Ph.D. In Vitro Blood Damage Assessment Lab Division of Solid and Fluid Mechanics](https://www.pdfsearch.io/img/a840d445cd8921854f9fbd55776b1bb4.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
4![PUBLIC WORKSHOP: RISK MITIGATION STRATEGIES TO ADDRESS PROCOAGULANT ACTIVITY IN IMMUNE GLOBULIN PRODUCTS PUBLIC WORKSHOP: RISK MITIGATION STRATEGIES TO ADDRESS PROCOAGULANT ACTIVITY IN IMMUNE GLOBULIN PRODUCTS](https://www.pdfsearch.io/img/efe5dfa3751ec45f269a404290c02fc4.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
5![Welcome and Overview of the Current FDA Approach to Thrombogenicity Evaluation Jennifer Goode, BS, Biomedical Engineer FDA Office of Device Evaluation Division of Cardiovascular Devices Welcome and Overview of the Current FDA Approach to Thrombogenicity Evaluation Jennifer Goode, BS, Biomedical Engineer FDA Office of Device Evaluation Division of Cardiovascular Devices](https://www.pdfsearch.io/img/b42a100e6fa27287cece550de4a00bfe.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
6![The FDA Perspective on Thrombogenicity Testing of Coronary Interventional Devices: Insights From the Large Animal Testing Michael C. John, MPH Circulatory Support Devices Branch The FDA Perspective on Thrombogenicity Testing of Coronary Interventional Devices: Insights From the Large Animal Testing Michael C. John, MPH Circulatory Support Devices Branch](https://www.pdfsearch.io/img/c42b09fda0c4d349624c7f387ea2bb72.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
7![Microsoft Word[removed]Thrombogenicity Panel Questions (final[removed]doc Microsoft Word[removed]Thrombogenicity Panel Questions (final[removed]doc](https://www.pdfsearch.io/img/8e833e5d24229ea5003d45f1c140713c.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|